Source:http://linkedlifedata.com/resource/pubmed/id/15536158
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2005-2-8
|
pubmed:abstractText |
In men, hypoandrogenism is associated with features of the metabolic syndrome. It is not known whether men with the metabolic syndrome are at a higher risk of developing hypogonadism. We therefore assessed whether the metabolic syndrome predicts development of hypogonadism 11 yr later in 651 middle-aged Finnish men participating in a population-based cohort study. Men with the metabolic syndrome at baseline as defined by the World Health Organization (n = 114, 20%) had a 2.6-fold increased risk of developing hypogonadism as defined by total testosterone levels less than 11 nmol/liter at the 11-yr follow-up independent of age, smoking, and other potential confounders. Further adjustment for body mass index (OR, 2.0; 95% CI, 1.1-3.8) or baseline total testosterone levels (OR, 1.9; 95% CI, 1.0-3.4) attenuated the association. The association of the metabolic syndrome with hypogonadism as defined by calculated free testosterone levels less than 225 pmol/liter was similar, but weaker. The adjusted decrease in testosterone concentrations during the 11-yr follow-up was also greater in men with than without the metabolic syndrome. Smokers had a nonsignificantly lower risk of developing hypogonadism during follow-up, whereas a decrease in smoking increased the risk of hypogonadism. The metabolic syndrome predisposes to development of hypogonadism in middle-aged men. Prevention of abdominal obesity and the accompanying metabolic syndrome in middle age may decrease the risk of hypogonadism in men, especially in those who quit smoking.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0021-972X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
90
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
712-9
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:15536158-Blood Glucose,
pubmed-meshheading:15536158-Blood Pressure,
pubmed-meshheading:15536158-Body Mass Index,
pubmed-meshheading:15536158-Cohort Studies,
pubmed-meshheading:15536158-Follow-Up Studies,
pubmed-meshheading:15536158-Humans,
pubmed-meshheading:15536158-Hypogonadism,
pubmed-meshheading:15536158-Male,
pubmed-meshheading:15536158-Metabolic Syndrome X,
pubmed-meshheading:15536158-Middle Aged,
pubmed-meshheading:15536158-Risk Factors,
pubmed-meshheading:15536158-Smoking,
pubmed-meshheading:15536158-Testosterone,
pubmed-meshheading:15536158-Time Factors,
pubmed-meshheading:15536158-Triglycerides
|
pubmed:year |
2005
|
pubmed:articleTitle |
The metabolic syndrome and smoking in relation to hypogonadism in middle-aged men: a prospective cohort study.
|
pubmed:affiliation |
Department of Medicine, Kuopio University, P.O. Box 1627, FIN-70211 Kuopio, Finland.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|